Here are relevant reports on : plant-tissue-culture-market
-
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027
The global legionella testing market growth is primed to transition from $296.0 million in 2022 to $439.0 million by 2027, showcasing a strong CAGR of 8.2%. The rising geriatric population, combined with the rising prevalence of legionella-related illness and rising demand for rapid diagnostics, is driving growth in this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Laboratory Proficiency Testing Market by Industry (Clinical Diagnostics, Microbiology, Pharmaceutical, Food & Animal Feed, Water, Opioid), Technology (PCR, Cell Culture), and Region; Unmet Needs, Stakeholder & Buying Criteria - Global Forecast to 2028
The global laboratory proficiency testing market, valued at US$1.1 billion in 2022, stood at US$1.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.4% from 2023 to 2028, culminating in a forecasted valuation of US$1.6 billion by the end of the period. The proficiency testing market is projected to experience substantial expansion in the forecasted period due to its mandatory requirement for laboratories operating in various regulated industries like APIAC, CLIA, and CLSI.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029
The global 3D bioprinting market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR of 12.7% from 2024 to 2029, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The market growth is fueled by the growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancements in 3D bioprinting, and the rising demand for organ transplants.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022
The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. The major players in the market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical.
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030
The global biosurgery market, valued at US$14.96 billion in 2024, stood at US$15.83 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.59 billion by the end of the period. Some of the prominent players operating in the market include market Medtronic (Ireland), Johnson & Johnson Services, Inc. (US), Baxter (US), Becton, Dickinson and Company (BD) (US), B. Braun SE (Germany), Stryker (US), Integra Lifesciences Holdings Corporation (US), CSL Ltd. (Australia), Hemostasis LLC (US), and Pfizer Inc. (US), among others.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Aerospace Tapes Market by Resin Type (Acrylic, Rubber, Silicone), Backing Material (Paper/Tissue, Film, Foam), End-use Industry (Commercial Aviation, Military Aviation, General Aviation), and Region - Global Forecast to 2024
The aerospace tapes market is expected to grow from USD 2.0 billion in 2019 to USD 2.4 billion by 2024, at a compound annual growth rate (CAGR) of 4.0%, during the forecast period.Major players operating in the aerospace tapes market include 3M Company (US), Nitto Denko Corporation (Japan), Avery Dennison Corporation (US), tesa SE (Germany), Scapa Group plc (UK), Intertape Polymer Group (Canada), Compagnie de Saint-Gobain S.A. (France), Berry Global, Inc. (US), Advance Tapes International (UK), Stokvis Tapes BV (Netherlands), Shurtape Technologies, LLC (US), DeWAL Industries (US), MBK Tape Solutions (US), GERGONNE - The Adhesive Solution (France), Adhesives Research, Inc. (US), American Biltrite Inc. (US), Can-Do National Tape, Inc. (US), Av-DEC, Inc. (US), JTAPE Limited (UK), Fralock Innovative Materials Manufacturing & Automation (US), UltraTape (US), and Mask-Off Company, Inc. (US).
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021
The global viral inactivation market is segmented on the basis of method, product, application, end user, and geography. By method, the market is divided into solvent detergent method, pasteurization, and other methods. The global viral inactivation market was valued at USD 320.5 Million in 2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021.
- Published: June 2016
- Price: $ 4950
- TOC Available:
-
Waste Paper Management Market by Service & Equipment (Collection & Transportation, Recycling, Incineration, Disposal), Recovery (Containerboard, Newsprint, Tissue), Source (Commercial, Industrial, Residential), Paper Grade - Global Forecast to 2020
The paper industry has been dominated by North America for more than a century now. North America is the largest producer as well as consumer of paper & paper products with a yearly per capita consumption of 487 pounds of paper. This region also enjoys significant availability of fiber resources, which enables it to hold the highest position in the global export of pulp & waste paper. The U.S. ranks first in pulp & paper manufacture and exports, globally, followed by Canada. The global waste paper management market is projected to be valued at around USD 43.35 Billion by 2020, and to grow at a CAGR of 2.55% from 2015 to 2020. The commercial sector as a source of waste paper is projected to grow at the highest CAGR from 2015 to 2020.
- Published: October 2015
- Price: $ 7150
- TOC Available:
-
Breast Reconstruction Market Size, Growth by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) & Region - Global Forecasts to 2026
The global breast reconstruction market in terms of revenue was estimated to be worth $567 million in 2021 and is poised to reach $647 million by 2026, growing at a CAGR of 2.7% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: March 2022
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
